Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Widwin Investment

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$17M
Portfolio companies 9
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Therapeutics

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AngelHub China, Hong Kong, Hong Kong Island
Ariba California, Sunnyvale, United States
Estlander & Partners -
Fengji Touzi China, Guangdong Province, Huizhou
FinRise -
Hengqinhexiang Venture China, Guangdong, Zhuhai
iVision Ventures Beijing, Beijing, China
Jiaxing Yuanqi Investment China, Jiaxing, Zhejiang
Lang & Schwarz Düsseldorf, Germany, Nordrhein-Westfalen
MulticoreWare California, Saratoga, United States
Panxi Capital Management -
Pilgrim, Baxter & Associates -
Qiu Zhang Dian Zi China, Shanghai
RFT Investment Company Atlanta, Georgia, United States
Riot Ventures California, Los Angeles, United States
Shanghai Jingzhi Enterprise Management China, Shanghai
Skyfall Ventures Norway, Oslo
Wosheng Cci Capital China, Guangxi, Jiangsu
Zhongxing Hongtai Touzi China, Shaanxi, Xian Shi
Zibo Qixin China, Qingdao Shi, Shandong

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Rodwin

Service Industry
Taxi Service
Training
Transportation
$15M09 May 2022 Seoul, Seoul-t'ukpyolsi, South Korea

BIORCHESTRA

Biopharma
Health Care
Medical
Therapeutics
$47M22 Feb 2022 South Korea, Gangwon-do, South Korea

iMediSync

Analytics
Health Care
Medical
$6M27 Jan 2022 Yeoksamdong, Seoul-t'ukpyolsi, South Korea

Rodwin

Service Industry
Taxi Service
Training
Transportation
$3M01 Jul 2021 Seoul, Seoul-t'ukpyolsi, South Korea

Newracle Genetics

Biotechnology
Medical
Pharmaceutical
$26M03 Jun 2021 Seoul, Seoul-t'ukpyolsi, South Korea

ProAbTech

Biopharma
Biotechnology
Pharmaceutical
$4M10 Aug 2020 South Korea, Gangwon-do, South Korea

SN BioScience

Biotechnology
02 Jul 2020 Seoul, Seoul-t'ukpyolsi, South Korea

Novelty Nobility

Biotechnology
Health Care
Life Science
Therapeutics
$8M04 Feb 2020 Seongnam, Kyonggi-do, South Korea

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Widwin Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 17M
Peak activity year 2020
Lead investments 0
Follow on index 0.10
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Rodwin

Service Industry
Taxi Service
Training
Transportation
$15M09 May 2022 Seoul, Seoul-t'ukpyolsi, South Korea

BIORCHESTRA

Biopharma
Health Care
Medical
Therapeutics
$47M22 Feb 2022 South Korea, Gangwon-do, South Korea

iMediSync

Analytics
Health Care
Medical
$6M27 Jan 2022 Yeoksamdong, Seoul-t'ukpyolsi, South Korea

Rodwin

Service Industry
Taxi Service
Training
Transportation
$3M01 Jul 2021 Seoul, Seoul-t'ukpyolsi, South Korea

Newracle Genetics

Biotechnology
Medical
Pharmaceutical
$26M03 Jun 2021 Seoul, Seoul-t'ukpyolsi, South Korea

ProAbTech

Biopharma
Biotechnology
Pharmaceutical
$4M10 Aug 2020 South Korea, Gangwon-do, South Korea

SN BioScience

Biotechnology
02 Jul 2020 Seoul, Seoul-t'ukpyolsi, South Korea

Novelty Nobility

Biotechnology
Health Care
Life Science
Therapeutics
$8M04 Feb 2020 Seongnam, Kyonggi-do, South Korea
Crunchbase icon

Content report

The following text will be sent to our editors: